Screener
Eligibility screening
Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck…
31 US sites in AZ, CA, CT, FL +14
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.